james_bowling

Shire interim chief financial officer resigns

pharmafile | October 21, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Shire, james bowling, merger 

Shire’s interim chief financial officer James Bowling has left the firm for water company Severn Trent following the collapse of AbbVie’s takeover deal.

Bowling (pictured) has informed Dublin-based Shire of his decision to step down as CFO in order to pursue a career at Severn Trent, which will commence next year at the end of the first quarter.

Bowling took on the job at Shire in February when Graham Hetherington ­– its finance director at the time – stepped down. 

Advertisement

Shire’s Danish chief executive Flemming Ornskov says: “James has helped build and lead a high-quality finance team at Shire,” before adding that the company will begin to search for a finance director replacement ‘immediately’.

This departure arrives amid AbbVie’s failed bid to purchase Shire for $52 billion in order move the combined company’s legal address to the UK (where it tax rates are lower than the US) in order to reduce its tax bill and access cash ‘trapped’ overseas.

Related Content

Genmab to submit FDA application for lymphoma therapy

Global biotechnology company Genmab plans to submit a supplemental Biologics License Application (sBLA) to the …

Stelis, Strides and Steriscience merge to form new CDMO

The CDMO launched earlier this year at the CPHI conference in Milan. The merger is …

The Gateway to Local Adoption Series

Latest content